"evaluation and testing services (ETS) for vaccines and other biologics for infectious diseases."
Active Indefinite Delivery Contract Awarded
- Contract number
- 75N93025D00019
- Awardee
-
Trustees Of Boston University UEI THL6A6JLE1S7
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Last date to order 11% complete
- IDV ceiling
- $136,588,701.00
- Maximum order
- $136,588,701.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 37 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The Trustees of Boston University has been awarded a single-award Indefinite Delivery Contract valued at $136.6 million by the National Institute of Allergy and Infectious Diseases (NIAID) to provide evaluation and testing services for vaccines and other biologics targeting infectious diseases. The contract, awarded on September 30, 2025, extends through September 29, 2035, establishing a ten-year partnership for specialized laboratory and analytical services. As a civilian agency within the National Institutes of Health, NIAID selected Boston University as the prime contractor without the application of any small business set-aside provisions, leveraging the university's established research infrastructure and scientific expertise in immunology and infectious disease research.
Boston University will deliver comprehensive preclinical and clinical evaluation services, including immunological testing, safety assessments, and efficacy evaluations for vaccine and biologic candidates under development. The contract encompasses laboratory analyses, quality control testing, and data analysis services essential to support NIAID's regulatory and research objectives in advancing medical countermeasures against infectious disease threats. Given Boston University's demonstrated capabilities as a major federal research institution with significant experience managing complex, multi-year research initiatives for federal agencies and established partnerships with the National Institutes of Health, the university is positioned to provide sustained scientific support throughout the contract period. This IDV structure allows NIAID to issue task orders for specific vaccine and biologic evaluation projects as programmatic needs arise, ensuring flexible allocation of the contract ceiling while maintaining continuity of testing and evaluation services.
Quick answers
Who was awarded contract 75N93025D00019?
75N93025D00019 was awarded to Trustees Of Boston University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2025.
How much is contract 75N93025D00019 worth?
75N93025D00019's own ceiling is $136,588,701. A single order can be worth up to $136,588,701.
Who can order from contract 75N93025D00019?
75N93025D00019 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N93025D00019 competed?
The extent of competition for 75N93025D00019 was full and open competition. The government received 37 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV